Evidence map›Paper›PMID 39886160›Full record

ArticleBMJ oncology2024

Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia.

Katayoun Taghavi, Misinzo Moono, Mulindi Mwanahamuntu, Marie Roumet, Andreas Limacher, Herbert Kapesa, Thamsanqa Madliwa, Anne Rutjes, Partha Basu, Nicola Low and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in BMJ oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03931083 (Screening Test Accuracy of a Gynocular™, HR-HPV Testing, and VIA for Detection of Cervical Intraepithelial Neoplasia, Grade Two and Above, in Women Living With HIV in Lusaka, Zambia), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03931083 unknown statusnot on this map

Screening Test Accuracy of a Gynocular™, HR-HPV Testing, and VIA for Detection of Cervical Intraepithelial Neoplasia, Grade Two and Above, in Women Living With HIV in Lusaka, Zambia

TypeobservationalSponsorUniversity of BernRan2019 to 2022Enrolled450ConditionsUterine Cervical Neoplasms, HIV/AIDSArmsScreening for CIN2+/HSIL
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Katayoun Taghavi *Institute of Social and Preventative Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0003-0812-0069
Misinzo Moono *Center for Infectious Disease Research in Zambia, Lusaka, Zambia.
Mulindi MwanahamuntuUniversity of Zambia University Teaching Hospital, Lusaka, Zambia.
Marie RoumetClinical Trials Unit, University of Bern, Bern, Switzerland.
Andreas LimacherClinical Trials Unit, University of Bern, Bern, Switzerland.
Herbert KapesaCenter for Infectious Disease Research in Zambia, Lusaka, Zambia.
Thamsanqa MadliwaDepartment of histopathology, Lancet Laboratories, Richmond, South Africa.
Anne RutjesInstitute of Social and Preventative Medicine, University of Bern, Bern, Switzerland.
Partha BasuInternational Agency for Research on Cancer, Lyon, France.
Nicola Low *Institute of Social and Preventative Medicine, University of Bern, Bern, Switzerland.
Albert Manasyan *Center for Infectious Disease Research in Zambia, Lusaka, Zambia.
Julia Bohlius *Institute of Social and Preventative Medicine, University of Bern, Bern, Switzerland.

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
NIAID NIH HHS U01 AI069924World Health Organization 001
6 · The paper itself

Abstract

Objective: This study aimed to provide evidence to improve cervical screening for women living with HIV (WLHIV). We assessed the accuracy of screening tests that can be used in low-resource settings and give results at the same visit. Methods and analysis: We conducted a paired, prospective study among consecutive eligible WLHIV, aged 18-65 years, receiving cervical cancer screening at one hospital in Lusaka, Zambia. The histopathological reference standard was multiple biopsies taken at two time points. The target condition was cervical intraepithelial neoplasia grade 2 and above (CIN2+). The index tests were high-risk human papillomavirus detection (hrHPV, Xpert HPV, Cepheid), portable colposcopy (Gynocular, Gynius) and visual inspection with acetic acid (VIA). Accuracy of stand-alone and test combinations were calculated as the point estimate with 95% CIs. A sensitivity analysis considered disease when only visible lesions were biopsied. Results: Women included in the study had well-controlled HIV infection (median CD4 count=542 cells/mm Conclusion: The low accuracy of screening tests assessed might be explained by our reference standard, which reduced verification and misclassification biases. Better screening strategies for WLHIV in low-resource settings are urgently needed. Trial registration number: NCT03931083.

Indexed as

cancer screeningcervical cancer

Identifiers

PMID39886160
PMCPMC11235020

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.